Archives for September 15, 2005

← 2005

ProEthic to bring Swiss delivery tech to North America

Applied Pharma Research, a Swiss R&D firm specialising in drug delivery, has granted an exclusive license to US drugmaker ProEthic Pharmaceuticals to develop and market two fast-acting formulations of the painkiller diclofenac potassium in the US and...

Wilco boosts throughput of vial tester

Switzerland's Wilco AG has developed a new version of its award winning headspace testing system for pharmaceutical vials that boosts its throughput by 50 per cent.

MedImmune purchases Cellective Therapeutics

By  Wai Lang Chu

Medimmune announced the signing of an agreement to acquire Cellective Therapeutics, in a deal that furthers its strategy of increasing new drug candidates in its specialist areas of cancer and autoimmune diseases such as lupus and rheumatoid arthritis.

EntreMed and NCI in cancer collaboration

By  Wai Lang Chu

EntreMed has entered into a research and development agreement with the National Cancer Institute (NCI) to evaluate the role of HIF-1alpha inhibition in the treatment of cancer. The agreement aims to establish the relationship between Entremed's lead...